Ikarian Capital, LLC Ultragenyx Pharmaceutical Inc. Call Options Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $5.36 Million - $6.62 Million	-73,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $1.24 Million - $2.07 Million	-26,500 Reduced 26.5%	73,500 $5.75 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $3.38 Million - $6.29 Million	100,000 New	100,000 $4.44 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.15B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.